144 related articles for article (PubMed ID: 31665948)
1. Antibodies against aberrant glycans as cancer biomarkers.
Blsakova A; Kveton F; Kasak P; Tkac J
Expert Rev Mol Diagn; 2019 Dec; 19(12):1057-1068. PubMed ID: 31665948
[No Abstract] [Full Text] [Related]
2. Polyclonal human antibodies against glycans bearing red meat-derived non-human sialic acid N-glycolylneuraminic acid are stable, reproducible, complex and vary between individuals: Total antibody levels are associated with colorectal cancer risk.
Samraj AN; Bertrand KA; Luben R; Khedri Z; Yu H; Nguyen D; Gregg CJ; Diaz SL; Sawyer S; Chen X; Eliassen H; Padler-Karavani V; Wu K; Khaw KT; Willett W; Varki A
PLoS One; 2018; 13(6):e0197464. PubMed ID: 29912879
[TBL] [Abstract][Full Text] [Related]
3. Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer.
Padler-Karavani V; Hurtado-Ziola N; Pu M; Yu H; Huang S; Muthana S; Chokhawala HA; Cao H; Secrest P; Friedmann-Morvinski D; Singer O; Ghaderi D; Verma IM; Liu YT; Messer K; Chen X; Varki A; Schwab R
Cancer Res; 2011 May; 71(9):3352-63. PubMed ID: 21505105
[TBL] [Abstract][Full Text] [Related]
4. Autoantibody biomarkers in the detection of cancer.
Cho-Chung YS
Biochim Biophys Acta; 2006 Jun; 1762(6):587-91. PubMed ID: 16730166
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies against heat shock proteins as biomarkers for the diagnosis and prognosis of cancer.
Shi L; Chevolot Y; Souteyrand E; Laurenceau E
Cancer Biomark; 2017; 18(2):105-116. PubMed ID: 27983529
[TBL] [Abstract][Full Text] [Related]
6. Glycan-specific antibodies as potential cancer biomarkers: a focus on microarray applications.
Tikhonov A; Smoldovskaya O; Feyzkhanova G; Kushlinskii N; Rubina A
Clin Chem Lab Med; 2020 Sep; 58(10):1611-1622. PubMed ID: 32324152
[TBL] [Abstract][Full Text] [Related]
7. Serum autoantibodies as biomarkers for early cancer detection.
Tan HT; Low J; Lim SG; Chung MC
FEBS J; 2009 Dec; 276(23):6880-904. PubMed ID: 19860826
[TBL] [Abstract][Full Text] [Related]
8. Serologic autoantibodies as diagnostic cancer biomarkers--a review.
Zaenker P; Ziman MR
Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2161-81. PubMed ID: 24057574
[TBL] [Abstract][Full Text] [Related]
9. Tumor-associated autoantibody signature for the early detection of gastric cancer.
Zayakin P; Ancāns G; Siliņa K; Meistere I; Kalniņa Z; Andrejeva D; Endzeliņš E; Ivanova L; Pismennaja A; Ruskule A; Doniņa S; Wex T; Malfertheiner P; Leja M; Linē A
Int J Cancer; 2013 Jan; 132(1):137-47. PubMed ID: 22684876
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of serum autoantibodies as biomarkers for pancreatic cancer detection.
Dumstrei K; Chen H; Brenner H
Oncotarget; 2016 Mar; 7(10):11151-64. PubMed ID: 26840568
[TBL] [Abstract][Full Text] [Related]
11. Detection of N-glycolylneuraminic acid biomarkers in sera from patients with ovarian cancer using an engineered N-glycolylneuraminic acid-specific lectin SubB2M.
Shewell LK; Wang JJ; Paton JC; Paton AW; Day CJ; Jennings MP
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):173-177. PubMed ID: 30415777
[TBL] [Abstract][Full Text] [Related]
12. From "Serum Sickness" to "Xenosialitis": Past, Present, and Future Significance of the Non-human Sialic Acid Neu5Gc.
Dhar C; Sasmal A; Varki A
Front Immunol; 2019; 10():807. PubMed ID: 31057542
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer.
Li P; Shi JX; Xing MT; Dai LP; Li JT; Zhang JY
Tumour Biol; 2017 Oct; 39(10):1010428317711662. PubMed ID: 29022480
[TBL] [Abstract][Full Text] [Related]
14. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated autoantibodies as diagnostic and prognostic biomarkers.
Heo CK; Bahk YY; Cho EW
BMB Rep; 2012 Dec; 45(12):677-85. PubMed ID: 23261052
[TBL] [Abstract][Full Text] [Related]
16. Usage of cancer associated autoantibodies in the detection of disease.
Dudas SP; Chatterjee M; Tainsky MA
Cancer Biomark; 2010; 6(5-6):257-70. PubMed ID: 20938086
[TBL] [Abstract][Full Text] [Related]
17. The sensitivity and specificity of serum glycan-based biomarkers for cancer detection.
Tang Y; Cui Y; Zhang S; Zhang L
Prog Mol Biol Transl Sci; 2019; 162():121-140. PubMed ID: 30905445
[TBL] [Abstract][Full Text] [Related]
18. Blood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer.
Chen H; Werner S; Tao S; Zörnig I; Brenner H
Cancer Lett; 2014 May; 346(2):178-87. PubMed ID: 24462820
[TBL] [Abstract][Full Text] [Related]
19. Autoantibody biomarkers for the detection of serous ovarian cancer.
Katchman BA; Chowell D; Wallstrom G; Vitonis AF; LaBaer J; Cramer DW; Anderson KS
Gynecol Oncol; 2017 Jul; 146(1):129-136. PubMed ID: 28427776
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Value of the Survivin Autoantibody in Four Types of Malignancies.
Xiu Y; Sun B; Jiang Y; Wang A; Liu L; Liu Y; Sun S; Huangfu M
Genet Test Mol Biomarkers; 2018 Jun; 22(6):384-389. PubMed ID: 29924656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
